Atul Damani

Atul Damani is a business analyst with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as a Business Analyst II at Novo Nordisk since September 2022, Atul specializes in compliance, CSV, validation, risk assessment, audit management, and investigations. Prior to this role, Atul worked at Wipro as an Analytical QA Reviewer from August 2021 to September 2022, focusing on the preparation and review of SOPs, quality management systems, CSV, and data analysis. Atul also held positions as a Senior Scientist and Senior Executive at BIOCON BIOLOGICS LIMITED and Biocon Limited, respectively, where responsibilities included project management, analytical review, and audit. Atul's educational background includes a Master of Science in Biotechnology from M.S. Ramaiah College of Education and a Bachelor of Science in Biotechnology from the University of Mumbai.